LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 78

Search options

  1. Article ; Online: The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.

    Gilon, Patrick

    Journal of molecular biology

    2020  Volume 432, Issue 5, Page(s) 1367–1394

    Abstract: Pancreatic α-cells are the major source of glucagon, a hormone that counteracts the hypoglycemic action of insulin and strongly contributes to the correction of acute hypoglycemia. The mechanisms by which glucose controls glucagon secretion are hotly ... ...

    Abstract Pancreatic α-cells are the major source of glucagon, a hormone that counteracts the hypoglycemic action of insulin and strongly contributes to the correction of acute hypoglycemia. The mechanisms by which glucose controls glucagon secretion are hotly debated, and it is still unclear to what extent this control results from a direct action of glucose on α-cells or is indirectly mediated by β- and/or δ-cells. Besides its hyperglycemic action, glucagon has many other effects, in particular on lipid and amino acid metabolism. Counterintuitively, glucagon seems also required for an optimal insulin secretion in response to glucose by acting on its cognate receptor and, even more importantly, on GLP-1 receptors. Patients with diabetes mellitus display two main alterations of glucagon secretion: a relative hyperglucagonemia that aggravates hyperglycemia, and an impaired glucagon response to hypoglycemia. Under metabolic stress states, such as diabetes, pancreatic α-cells also secrete GLP-1, a glucose-lowering hormone, whereas the gut can produce glucagon. The contribution of extrapancreatic glucagon to the abnormal glucose homeostasis is unclear. Here, I review the possible mechanisms of control of glucagon secretion and the role of α-cells on islet function in healthy state. I discuss the possible causes of the abnormal glucagonemia in diabetes, with particular emphasis on type 2 diabetes, and I briefly comment the current antidiabetic therapies affecting α-cells.
    MeSH term(s) Animals ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/therapy ; Glucagon/metabolism ; Glucagon-Like Peptide 1/metabolism ; Glucagon-Like Peptide-1 Receptor/metabolism ; Glucagon-Secreting Cells/metabolism ; Glucose/metabolism ; Humans ; Hypoglycemia/physiopathology ; Hypoglycemia/therapy ; Insulin/metabolism
    Chemical Substances Glucagon-Like Peptide-1 Receptor ; Insulin ; Glucagon-Like Peptide 1 (89750-14-1) ; Glucagon (9007-92-5) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2020-01-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80229-3
    ISSN 1089-8638 ; 0022-2836
    ISSN (online) 1089-8638
    ISSN 0022-2836
    DOI 10.1016/j.jmb.2020.01.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: 3D evaluation of the extracellular matrix of hypoxic pancreatic islets using light sheet fluorescence microscopy.

    Ramirez, Matias / Bastien, Estelle / Chae, Heeyoung / Gianello, Pierre / Gilon, Patrick / Bouzin, Caroline

    Islets

    2024  Volume 16, Issue 1, Page(s) 2298518

    Abstract: Pancreatic islet transplantation is a promising treatment for type 1 diabetes, but the survival and function of transplanted islets are hindered by the loss of extracellular matrix (ECM) during islet isolation and by low oxygenation upon implantation. ... ...

    Abstract Pancreatic islet transplantation is a promising treatment for type 1 diabetes, but the survival and function of transplanted islets are hindered by the loss of extracellular matrix (ECM) during islet isolation and by low oxygenation upon implantation. This study aimed to evaluate the impact of hypoxia on ECM using a cutting-edge imaging approach based on tissue clearing and 3D microscopy. Human and rat islets were cultured under normoxic (O
    MeSH term(s) Humans ; Animals ; Rats ; Microscopy, Fluorescence ; Islets of Langerhans ; Extracellular Matrix ; Hypoxia ; Extracellular Matrix Proteins ; Cadherins
    Chemical Substances Extracellular Matrix Proteins ; Cadherins
    Language English
    Publishing date 2024-01-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2589489-4
    ISSN 1938-2022 ; 1938-2022
    ISSN (online) 1938-2022
    ISSN 1938-2022
    DOI 10.1080/19382014.2023.2298518
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cocaine- and amphetamine-regulated transcript: a novel regulator of energy homeostasis expressed in a subpopulation of pancreatic islet cells.

    Gilon, Patrick

    Diabetologia

    2016  Volume 59, Issue 9, Page(s) 1855–1859

    Abstract: Type 2 diabetes is characterised by chronic hyperglycaemia and its incidence is highly increased by exaggerated food consumption. It results from a lack of insulin action/production, but growing evidence suggests that it might also involve ... ...

    Abstract Type 2 diabetes is characterised by chronic hyperglycaemia and its incidence is highly increased by exaggerated food consumption. It results from a lack of insulin action/production, but growing evidence suggests that it might also involve hyperglucagonaemia and impaired control of glucose homeostasis by the brain. In recent years, the cocaine and amphetamine-regulated transcript (CART) peptides have generated a lot of interest in the battle against obesity because, via the brain, they exert anorexic effects and they increase energy expenditure. They are also localised, outside the brain, in discrete regions of the body and play a hormonal role in controlling various functions. In this issue of Diabetologia, the Wierup group (doi: 10.1007/s00125-016-4020-6 ) shows that CART peptides are expressed heterogeneously in islet cells of various species, including humans, and that their expression is upregulated in diabetes. The authors also shine a spotlight on some interesting effects of CART peptides on islet function, including stimulation of insulin secretion and inhibition of glucagon release. CART peptides would thus be at the centre of a cooperation between the brain and the endocrine pancreas to control glucose homeostasis. Although the mechanisms of action of CART peptides remain enigmatic because no specific receptor for these peptides has so far been discovered, their potential therapeutic use is evident and represents a new challenge for future research.
    MeSH term(s) Animals ; Brain/metabolism ; Diabetes Mellitus, Type 2/metabolism ; Glucagon/metabolism ; Homeostasis/genetics ; Homeostasis/physiology ; Humans ; Hyperglycemia/metabolism ; Insulin/metabolism ; Islets of Langerhans/metabolism ; Nerve Tissue Proteins/metabolism
    Chemical Substances Insulin ; Nerve Tissue Proteins ; cocaine- and amphetamine-regulated transcript protein ; Glucagon (9007-92-5)
    Language English
    Publishing date 2016-09
    Publishing country Germany
    Document type Editorial
    ZDB-ID 1694-9
    ISSN 1432-0428 ; 0012-186X
    ISSN (online) 1432-0428
    ISSN 0012-186X
    DOI 10.1007/s00125-016-4052-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Glucose inhibits glucagon secretion by decreasing [Ca

    Singh, Bilal / Khattab, Firas / Gilon, Patrick

    Molecular metabolism

    2022  Volume 61, Page(s) 101495

    Abstract: Objective: The mechanisms by which glucose stimulates insulin secretion from β-cells are well established and involve inhibition of ATP-sensitive K: Methods: We tested the effect of a decrease or an increase of glucose concentration (Gx, with x = ... ...

    Abstract Objective: The mechanisms by which glucose stimulates insulin secretion from β-cells are well established and involve inhibition of ATP-sensitive K
    Methods: We tested the effect of a decrease or an increase of glucose concentration (Gx, with x = concentration in mM) on α-cell [Ca
    Results: Blockade of K
    Conclusions: We propose a model according to which glucose controls α-cell [Ca
    MeSH term(s) Adenosine Triphosphate ; Animals ; Calcium/metabolism ; Cations, Divalent/metabolism ; Exocytosis/physiology ; Glucagon/biosynthesis ; Glucagon/metabolism ; Glucagon-Secreting Cells/metabolism ; Glucose/analysis ; Glucose/metabolism ; KATP Channels/metabolism ; Mice ; Somatostatin/metabolism
    Chemical Substances Cations, Divalent ; KATP Channels ; Somatostatin (51110-01-1) ; Adenosine Triphosphate (8L70Q75FXE) ; Glucagon (9007-92-5) ; Glucose (IY9XDZ35W2) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2022-04-11
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2708735-9
    ISSN 2212-8778 ; 2212-8778
    ISSN (online) 2212-8778
    ISSN 2212-8778
    DOI 10.1016/j.molmet.2022.101495
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Corrigendum to "Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells" [Mol Metab 2016 May; 5 (5): 366-378].

    Boothe, Tobias / Lim, Gareth E / Cen, Haoning / Skovsø, Søs / Piske, Micah / Li, Shu Nan / Nabi, Ivan R / Gilon, Patrick / Johnson, James D

    Molecular metabolism

    2024  Volume 83, Page(s) 101935

    Language English
    Publishing date 2024-04-08
    Publishing country Germany
    Document type Published Erratum
    ZDB-ID 2708735-9
    ISSN 2212-8778 ; 2212-8778
    ISSN (online) 2212-8778
    ISSN 2212-8778
    DOI 10.1016/j.molmet.2024.101935
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Glucose inhibits glucagon secretion by decreasing [Ca2+]c and by reducing the efficacy of Ca2+ on exocytosis via somatostatin-dependent and independent mechanisms

    Bilal Singh / Firas Khattab / Patrick Gilon

    Molecular Metabolism, Vol 61, Iss , Pp 101495- (2022)

    2022  

    Abstract: Objective: The mechanisms by which glucose stimulates insulin secretion from β-cells are well established and involve inhibition of ATP-sensitive K+ (KATP) channels, followed by a rise in [Ca2+]c that triggers exocytosis. However, the mechanisms by which ...

    Abstract Objective: The mechanisms by which glucose stimulates insulin secretion from β-cells are well established and involve inhibition of ATP-sensitive K+ (KATP) channels, followed by a rise in [Ca2+]c that triggers exocytosis. However, the mechanisms by which glucose controls glucagon release from α-cells are much less known. In particular, it is debated whether the sugar controls glucagon secretion by changing α-cell [Ca2+]c, and whether KATP channels or paracrine factors are involved. The present study addresses these issues. Methods: We tested the effect of a decrease or an increase of glucose concentration (Gx, with x = concentration in mM) on α-cell [Ca2+]c and glucagon secretion. α-cell [Ca2+]c was monitored using GluCreGCaMP6f mice expressing the Ca2+-sensitive fluorescent protein, GCaMP6f, specifically in α-cells. [Ca2+]c was compared between dispersed α-cells and α-cells within islets to evaluate the potential contribution of an indirect effect of glucose. The same protocols were used for experiments of glucagon secretion from whole islets and [Ca2+]c measurements to test if changes in glucagon release mirror those in α-cell [Ca2+]c. Results: Blockade of KATP channels by sulfonylureas (tolbutamide 100 μM or gliclazide 25 μM) strongly increased [Ca2+]c in both dispersed α-cells and α-cells within islets. By contrast, glucose had no effect on [Ca2+]c in dispersed α-cells, whereas it affected it in α-cells within islets. The effect of glucose was however different in islets expressing (Sst+/+) or not somatostatin (SST) (Sst−/−). Decreasing glucose concentration from G7 to G1 modestly increased α-cell [Ca2+]c, but to a slightly larger extent in Sst+/+ islets than in Sst−/− islets. This G1-induced [Ca2+]c rise was also observed in the continuous presence of sulfonylureas in both Sst+/+ and Sst−/− islets. Increasing glucose concentration from G7 to G20 did not affect α-cell [Ca2+]c in Sst+/+ islets which remained low, whereas it strongly increased it in Sst−/− islets. The observations that this increase was seen ...
    Keywords Pancreatic islets ; KATP channels ; Ca2+ ; Glucagon ; Somatostatin ; Internal medicine ; RC31-1245
    Subject code 570
    Language English
    Publishing date 2022-07-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: ER stress increases expression of intracellular calcium channel RyR1 to modify Ca

    Zhang, Irina X / Herrmann, Andrea / Leon, Juan / Jeyarajan, Sivakumar / Arunagiri, Anoop / Arvan, Peter / Gilon, Patrick / Satin, Leslie S

    The Journal of biological chemistry

    2023  Volume 299, Issue 8, Page(s) 105065

    Abstract: Pancreatic beta cells maintain glucose homeostasis by secreting pulses of insulin in response to a rise in plasma glucose. Pulsatile insulin secretion occurs as a result of glucose-induced oscillations in beta-cell cytosolic ... ...

    Abstract Pancreatic beta cells maintain glucose homeostasis by secreting pulses of insulin in response to a rise in plasma glucose. Pulsatile insulin secretion occurs as a result of glucose-induced oscillations in beta-cell cytosolic Ca
    MeSH term(s) Animals ; Mice ; Apoptosis ; Calcium Signaling ; Diabetes Mellitus, Type 2/metabolism ; Endoplasmic Reticulum Stress ; Glucose/metabolism ; Homeostasis ; Insulin-Secreting Cells/metabolism ; Ryanodine Receptor Calcium Release Channel/genetics ; Ryanodine Receptor Calcium Release Channel/metabolism ; Tunicamycin ; Rats ; Cell Line
    Chemical Substances Glucose (IY9XDZ35W2) ; ryanodine receptor 1, mouse ; Ryanodine Receptor Calcium Release Channel ; Tunicamycin (11089-65-9)
    Language English
    Publishing date 2023-07-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1016/j.jbc.2023.105065
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function.

    Zaïmia, Nour / Obeid, Joelle / Varrault, Annie / Sabatier, Julia / Broca, Christophe / Gilon, Patrick / Costes, Safia / Bertrand, Gyslaine / Ravier, Magalie A

    Cell reports

    2023  Volume 42, Issue 11, Page(s) 113326

    Abstract: Glucagon-like peptide 1 (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIPR) receptors are G-protein-coupled receptors involved in glucose homeostasis. Diabetogenic conditions decrease β-arrestin 2 (ARRB2) levels in human islets. In mouse β ... ...

    Abstract Glucagon-like peptide 1 (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIPR) receptors are G-protein-coupled receptors involved in glucose homeostasis. Diabetogenic conditions decrease β-arrestin 2 (ARRB2) levels in human islets. In mouse β cells, ARRB2 dampens insulin secretion by partially uncoupling cyclic AMP (cAMP)/protein kinase A (PKA) signaling at physiological doses of GLP-1, whereas at pharmacological doses, the activation of extracellular signal-related kinase (ERK)/cAMP-responsive element-binding protein (CREB) requires ARRB2. In contrast, GIP-potentiated insulin secretion needs ARRB2 in mouse and human islets. The GIPR-ARRB2 axis is not involved in cAMP/PKA or ERK signaling but does mediate GIP-induced F-actin depolymerization. Finally, the dual GLP-1/GIP agonist tirzepatide does not require ARRB2 for the potentiation of insulin secretion. Thus, ARRB2 plays distinct roles in regulating GLP-1R and GIPR signaling, and we highlight (1) its role in the physiological context and the possible functional consequences of its decreased expression in pathological situations such as diabetes and (2) the importance of assessing the signaling pathways engaged by the agonists (biased/dual) for therapeutic purposes.
    MeSH term(s) Mice ; Humans ; Animals ; Insulin-Secreting Cells/metabolism ; Glucagon-Like Peptide 1/metabolism ; Insulin/metabolism ; beta-Arrestin 2/metabolism ; beta-Arrestin 1/metabolism ; Glucose/metabolism
    Chemical Substances Glucagon-Like Peptide 1 (89750-14-1) ; Insulin ; beta-Arrestin 2 ; beta-Arrestin 1 ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2023-10-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2023.113326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Can Tea Extracts Exert a Protective Effect Against Diabetes by Reducing Oxidative Stress and Decreasing Glucotoxicity in Pancreatic β-Cells?

    Chae, Heeyoung / Gilon, Patrick

    Diabetes & metabolism journal

    2015  Volume 39, Issue 1, Page(s) 27–30

    Language English
    Publishing date 2015-02
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2602402-0
    ISSN 2233-6087 ; 2233-6079
    ISSN (online) 2233-6087
    ISSN 2233-6079
    DOI 10.4093/dmj.2015.39.1.27
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: K

    Singh, Bilal / Khattab, Firas / Chae, Heeyoung / Desmet, Lieven / Herrera, Pedro L / Gilon, Patrick

    Molecular metabolism

    2021  Volume 53, Page(s) 101268

    Abstract: Objective: Glucagon is secreted by pancreatic α-cells in response to hypoglycemia and its hyperglycemic effect helps to restore normal blood glucose. Insulin and somatostatin (SST) secretions from β- and δ-cells, respectively, are stimulated by glucose ... ...

    Abstract Objective: Glucagon is secreted by pancreatic α-cells in response to hypoglycemia and its hyperglycemic effect helps to restore normal blood glucose. Insulin and somatostatin (SST) secretions from β- and δ-cells, respectively, are stimulated by glucose by mechanisms involving an inhibition of their ATP-sensitive K
    Methods: Using a transgenic mouse model expressing the Ca
    Results: Application of the sulfonylureas, tolbutamide, or gliclazide, to a medium containing 1 mM or 15 mM glucose increased [Ca
    Conclusions: Sulfonylureas exert two opposite actions on α-cells: a direct stimulation as in β-cells and an indirect inhibition by SST. This suggests that any alteration of SST paracrine influence, as described in diabetes, will modify the effect of sulfonylureas on glucagon release. In addition, we suggest that δ-cells inhibit α-cells more efficiently than β-cells.
    MeSH term(s) Animals ; Calcium/metabolism ; Gliclazide/chemistry ; Gliclazide/pharmacology ; Glucagon/metabolism ; Glucagon-Secreting Cells/drug effects ; Glucagon-Secreting Cells/metabolism ; KATP Channels/antagonists & inhibitors ; KATP Channels/metabolism ; Mice ; Mice, Knockout ; Mice, Transgenic ; Potassium Channel Blockers/chemistry ; Potassium Channel Blockers/pharmacology ; Somatostatin/chemistry ; Somatostatin/pharmacology ; Tolbutamide/chemistry ; Tolbutamide/pharmacology
    Chemical Substances KATP Channels ; Potassium Channel Blockers ; Somatostatin (51110-01-1) ; Glucagon (9007-92-5) ; Tolbutamide (982XCM1FOI) ; Gliclazide (G4PX8C4HKV) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2021-06-09
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2708735-9
    ISSN 2212-8778 ; 2212-8778
    ISSN (online) 2212-8778
    ISSN 2212-8778
    DOI 10.1016/j.molmet.2021.101268
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top